DAMORA THERAPEUT(DMRA)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

DMRA DAMORA THERAPEUT

已收盘 08-28 16:00:00 EDT

29.00

-1.60

-5.23%

盘后29.00

+0.000.00%

19:30 EDT

最高30.71	最低28.42	成交量37.17万
今开30.38	昨收30.60	日振幅7.50%
总市值17.85亿	流通市值13.82亿	总股本6,155万
成交额1,080万	换手率0.78%	流通股本4,765万
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"DMRA","market":"US","secType":"STK","nameCN":"DAMORA THERAPEUT","latestPrice":29,"timestamp":1787947200000,"preClose":30.6,"halted":0,"volume":371724,"hourTrading":{"tag":"盘后","latestPrice":29,"preClose":29,"latestTime":"19:30 EDT","volume":8360,"amount":242440,"timestamp":1787959804748,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.05228758169934645,"floatShares":47648701,"shares":61553200,"eps":-9.876431,"marketStatus":"已收盘","change":-1.6,"latestTime":"08-28 16:00:00 EDT","open":30.38,"high":30.71,"low":28.415,"amount":10803306.81204,"amplitude":0.075,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-9.876431,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1788163200000},"marketStatusCode":5,"adr":0,"listingDate":1603944000000,"exchange":"NASDAQ","adjPreClose":30.6,"preHourTrading":{"tag":"盘前","latestPrice":30.1,"preClose":30.6,"latestTime":"09:29 EDT","volume":3,"amount":91.540002,"timestamp":1787923799003,"change":-0.5,"changeRate":-0.01634,"amplitude":0.040523},"postHourTrading":{"tag":"盘后","latestPrice":29,"preClose":29,"latestTime":"19:30 EDT","volume":8360,"amount":242440,"timestamp":1787959804748,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":1.782683},"requestUrl":"/m/hq/s/DMRA","defaultTab":"news","newsList":[{"id":"1112635870","title":"Damora Therapeutics启动Dmr-001治疗突变CALR驱动型原发性血小板增多症与骨髓纤维化的Clarity-101 1/1B期临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1112635870","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1112635870?lang=zh_cn&edition=full","pubTime":"2026-08-05 20:01","pubTimestamp":1785931269,"startTime":"0","endTime":"0","summary":"Damora Therapeutics正式启动一项名为Clarity-101的1/1B期临床试验，旨在评估其候选药物Dmr-001在突变型钙网蛋白驱动的原发性血小板增多症及骨髓纤维化患者中的疗效与安全性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DMRA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1105165649","title":"杰富瑞首次覆盖Damora Therapeutics，给予买入评级，目标价50美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1105165649","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1105165649?lang=zh_cn&edition=full","pubTime":"2026-07-27 14:03","pubTimestamp":1785132188,"startTime":"0","endTime":"0","summary":"杰富瑞（Jefferies）近日对Damora Therapeutics（重组前）启动覆盖研究，给予其“买入”评级，并将目标股价设定为50美元。这一举措凸显了市场对该公司发展前景的乐观预期，分析师认为其具备显著的成长潜力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["DMRA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151744301","title":"Galecto Inc旗下Damora计划于2026年中提交DMR-001新药临床试验申请 概念验证数据预计2027年中公布","url":"https://stock-news.laohu8.com/highlight/detail?id=1151744301","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/1151744301?lang=zh_cn&edition=full","pubTime":"2026-03-09 20:07","pubTimestamp":1773058034,"startTime":"0","endTime":"0","summary":"生物技术公司Galecto Inc.近日披露其子公司Damora的最新研发进展。根据规划，Damora拟于2026年中期向监管机构提交DMR-001的新药临床试验申请或临床试验授权，该时间表标志着其在纤维化疾病治疗领域的重要里程碑。与此同时，针对DMR-001的概念验证关键数据集预计将在2027年中期揭晓。此次进展凸显了Galecto Inc.通过Damora平台深化其在创新疗法领域的战略布局。若后续研究顺利推进，DMR-001有望为特定纤维化疾病患者提供新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","GLTO","DMRA"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.damoratx.com","stockEarnings":[{"period":"1week","weight":0.0096},{"period":"1month","weight":0.0401},{"period":"3month","weight":0.2299},{"period":"6month","weight":0.0345},{"period":"1year","weight":8.1071},{"period":"ytd","weight":0.3299}],"compareEarnings":[{"period":"1week","weight":0.0111},{"period":"1month","weight":0.0408},{"period":"3month","weight":0.0193},{"period":"6month","weight":0.1241},{"period":"1year","weight":0.1925},{"period":"ytd","weight":0.1308}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Damora Therapeutics, Inc.于2019年10月在特拉华州注册成立，并于2026年7月20日在开曼群岛重新注册成立。该公司是一家专注于重新定义血液系统疾病患者治疗方案的创新型生物技术公司。该公司正在推进新一代生物制剂的研发，旨在治疗突变钙网蛋白驱动的骨髓增生性肿瘤，包括原发性血小板增多症和骨髓纤维化，这些疾病亟需能够改善病情的治疗方案。Damora的多个项目展现出同类最佳的潜力，并计划于2026年进入临床开发阶段。公司的目标是快速推出优化疗法，这些疗法不仅覆盖广泛的突变类型，而且使用极其便捷，最终目标是显著改善患者的治疗效果。","yearOnYearQuotes":[{"month":1,"riseRate":0.5,"avgChangeRate":0.139908},{"month":2,"riseRate":0.333333,"avgChangeRate":-0.041874},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.108508},{"month":4,"riseRate":0,"avgChangeRate":-0.108399},{"month":5,"riseRate":0.333333,"avgChangeRate":-0.014529},{"month":6,"riseRate":0.666667,"avgChangeRate":0.06096},{"month":7,"riseRate":0.5,"avgChangeRate":0.044864},{"month":8,"riseRate":0.5,"avgChangeRate":-0.093542},{"month":9,"riseRate":0.6,"avgChangeRate":0.012323},{"month":10,"riseRate":0.4,"avgChangeRate":0.0502},{"month":11,"riseRate":0.5,"avgChangeRate":0.174574},{"month":12,"riseRate":0.5,"avgChangeRate":-0.010261}],"exchange":"NASDAQ","name":"DAMORA THERAPEUT","nameEN":"DAMORA THERAPEUT"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"DAMORA THERAPEUT(DMRA)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供DAMORA THERAPEUT(DMRA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"DAMORA THERAPEUT,DMRA,DAMORA THERAPEUT股票,DAMORA THERAPEUT股票老虎,DAMORA THERAPEUT股票老虎国际,DAMORA THERAPEUT行情,DAMORA THERAPEUT股票行情,DAMORA THERAPEUT股价,DAMORA THERAPEUT股市,DAMORA THERAPEUT股票价格,DAMORA THERAPEUT股票交易,DAMORA THERAPEUT股票购买,DAMORA THERAPEUT股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"DAMORA THERAPEUT(DMRA)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供DAMORA THERAPEUT(DMRA)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}